Acetazolamide for Idiopathic Intracranial Hypertension: An Up-to-Date Review in 2025
Jaffer Naqvi1, Michael Wall1, Sophia M Chung1
1Department of Ophthalmology and Visual Science, Neuro-Ophthalmology Division, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Abstract:
Idiopathic Intracranial Hypertension (IIH) is characterized by elevated intracranial pressure in the absence of secondary causes. The treatment of IIH entails a combination of lifestyle modifications, medical therapy, and surgical intervention. This article aims to evaluate the role of acetazolamide in the treatment of IIH and identify its mechanism of action, efficacy, and side effect profile. This article also aims to discuss acetazolamide's role in conjunction with other treatment modalities.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Antihypertensive Drugs: Thiazide-Class Diuretics
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...


